Global Companion Diagnostics for Oncology Market Research Report 2024(Status and Outlook)
Report Overview:
Companion diagnostic (CDx) is a diagnostic testing kit majorly used by pharmaceutical companies for the development of personalized medicine. CDx tests provide information about the effective use of a corresponding therapeutic product by analyzing the genetic material. With the rise in cancer prevalence, coupled with increasing strategic initiatives, there has been a huge demand for companion diagnostics in the oncology area.
The Global Companion Diagnostics for Oncology Market Size was estimated at USD 4545.53 million in 2023 and is projected to reach USD 8410.53 million by 2029, exhibiting a CAGR of 10.80% during the forecast period.
This report provides a deep insight into the global Companion Diagnostics for Oncology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Companion Diagnostics for Oncology Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Companion Diagnostics for Oncology market in any manner.
Global Companion Diagnostics for Oncology Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Agilent Technologies
Illumina
Roche
BioMйrieux
Foundation Medicine
ArcherDX
Qiagen
Thermo Fisher Scientific
Amoy Diagnostics
Abbott
Market Segmentation (by Type)
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Market Segmentation (by Application)
Pharmaceutical and Biopharmaceutical Companies
Contract Research Organizations
Laboratories
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Companion Diagnostics for Oncology Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Companion diagnostic (CDx) is a diagnostic testing kit majorly used by pharmaceutical companies for the development of personalized medicine. CDx tests provide information about the effective use of a corresponding therapeutic product by analyzing the genetic material. With the rise in cancer prevalence, coupled with increasing strategic initiatives, there has been a huge demand for companion diagnostics in the oncology area.
The Global Companion Diagnostics for Oncology Market Size was estimated at USD 4545.53 million in 2023 and is projected to reach USD 8410.53 million by 2029, exhibiting a CAGR of 10.80% during the forecast period.
This report provides a deep insight into the global Companion Diagnostics for Oncology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Companion Diagnostics for Oncology Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Companion Diagnostics for Oncology market in any manner.
Global Companion Diagnostics for Oncology Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Agilent Technologies
Illumina
Roche
BioMйrieux
Foundation Medicine
ArcherDX
Qiagen
Thermo Fisher Scientific
Amoy Diagnostics
Abbott
Market Segmentation (by Type)
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Market Segmentation (by Application)
Pharmaceutical and Biopharmaceutical Companies
Contract Research Organizations
Laboratories
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Companion Diagnostics for Oncology Market
- Overview of the regional outlook of the Companion Diagnostics for Oncology Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Companion Diagnostics for Oncology Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Companion Diagnostics for Oncology
1.2 Key Market Segments
1.2.1 Companion Diagnostics for Oncology Segment by Type
1.2.2 Companion Diagnostics for Oncology Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Companion Diagnostics for Oncology Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Companion Diagnostics for Oncology Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET COMPETITIVE LANDSCAPE
3.1 Global Companion Diagnostics for Oncology Sales by Manufacturers (2019-2024)
3.2 Global Companion Diagnostics for Oncology Revenue Market Share by Manufacturers (2019-2024)
3.3 Companion Diagnostics for Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Companion Diagnostics for Oncology Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Companion Diagnostics for Oncology Sales Sites, Area Served, Product Type
3.6 Companion Diagnostics for Oncology Market Competitive Situation and Trends
3.6.1 Companion Diagnostics for Oncology Market Concentration Rate
3.6.2 Global 5 and 10 Largest Companion Diagnostics for Oncology Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 COMPANION DIAGNOSTICS FOR ONCOLOGY INDUSTRY CHAIN ANALYSIS
4.1 Companion Diagnostics for Oncology Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Companion Diagnostics for Oncology Sales Market Share by Type (2019-2024)
6.3 Global Companion Diagnostics for Oncology Market Size Market Share by Type (2019-2024)
6.4 Global Companion Diagnostics for Oncology Price by Type (2019-2024)
7 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Companion Diagnostics for Oncology Market Sales by Application (2019-2024)
7.3 Global Companion Diagnostics for Oncology Market Size (M USD) by Application (2019-2024)
7.4 Global Companion Diagnostics for Oncology Sales Growth Rate by Application (2019-2024)
8 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET SEGMENTATION BY REGION
8.1 Global Companion Diagnostics for Oncology Sales by Region
8.1.1 Global Companion Diagnostics for Oncology Sales by Region
8.1.2 Global Companion Diagnostics for Oncology Sales Market Share by Region
8.2 North America
8.2.1 North America Companion Diagnostics for Oncology Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Companion Diagnostics for Oncology Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Companion Diagnostics for Oncology Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Companion Diagnostics for Oncology Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Companion Diagnostics for Oncology Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Agilent Technologies
9.1.1 Agilent Technologies Companion Diagnostics for Oncology Basic Information
9.1.2 Agilent Technologies Companion Diagnostics for Oncology Product Overview
9.1.3 Agilent Technologies Companion Diagnostics for Oncology Product Market Performance
9.1.4 Agilent Technologies Business Overview
9.1.5 Agilent Technologies Companion Diagnostics for Oncology SWOT Analysis
9.1.6 Agilent Technologies Recent Developments
9.2 Illumina
9.2.1 Illumina Companion Diagnostics for Oncology Basic Information
9.2.2 Illumina Companion Diagnostics for Oncology Product Overview
9.2.3 Illumina Companion Diagnostics for Oncology Product Market Performance
9.2.4 Illumina Business Overview
9.2.5 Illumina Companion Diagnostics for Oncology SWOT Analysis
9.2.6 Illumina Recent Developments
9.3 Roche
9.3.1 Roche Companion Diagnostics for Oncology Basic Information
9.3.2 Roche Companion Diagnostics for Oncology Product Overview
9.3.3 Roche Companion Diagnostics for Oncology Product Market Performance
9.3.4 Roche Companion Diagnostics for Oncology SWOT Analysis
9.3.5 Roche Business Overview
9.3.6 Roche Recent Developments
9.4 BioMйrieux
9.4.1 BioMйrieux Companion Diagnostics for Oncology Basic Information
9.4.2 BioMйrieux Companion Diagnostics for Oncology Product Overview
9.4.3 BioMйrieux Companion Diagnostics for Oncology Product Market Performance
9.4.4 BioMйrieux Business Overview
9.4.5 BioMйrieux Recent Developments
9.5 Foundation Medicine
9.5.1 Foundation Medicine Companion Diagnostics for Oncology Basic Information
9.5.2 Foundation Medicine Companion Diagnostics for Oncology Product Overview
9.5.3 Foundation Medicine Companion Diagnostics for Oncology Product Market Performance
9.5.4 Foundation Medicine Business Overview
9.5.5 Foundation Medicine Recent Developments
9.6 ArcherDX
9.6.1 ArcherDX Companion Diagnostics for Oncology Basic Information
9.6.2 ArcherDX Companion Diagnostics for Oncology Product Overview
9.6.3 ArcherDX Companion Diagnostics for Oncology Product Market Performance
9.6.4 ArcherDX Business Overview
9.6.5 ArcherDX Recent Developments
9.7 Qiagen
9.7.1 Qiagen Companion Diagnostics for Oncology Basic Information
9.7.2 Qiagen Companion Diagnostics for Oncology Product Overview
9.7.3 Qiagen Companion Diagnostics for Oncology Product Market Performance
9.7.4 Qiagen Business Overview
9.7.5 Qiagen Recent Developments
9.8 Thermo Fisher Scientific
9.8.1 Thermo Fisher Scientific Companion Diagnostics for Oncology Basic Information
9.8.2 Thermo Fisher Scientific Companion Diagnostics for Oncology Product Overview
9.8.3 Thermo Fisher Scientific Companion Diagnostics for Oncology Product Market Performance
9.8.4 Thermo Fisher Scientific Business Overview
9.8.5 Thermo Fisher Scientific Recent Developments
9.9 Amoy Diagnostics
9.9.1 Amoy Diagnostics Companion Diagnostics for Oncology Basic Information
9.9.2 Amoy Diagnostics Companion Diagnostics for Oncology Product Overview
9.9.3 Amoy Diagnostics Companion Diagnostics for Oncology Product Market Performance
9.9.4 Amoy Diagnostics Business Overview
9.9.5 Amoy Diagnostics Recent Developments
9.10 Abbott
9.10.1 Abbott Companion Diagnostics for Oncology Basic Information
9.10.2 Abbott Companion Diagnostics for Oncology Product Overview
9.10.3 Abbott Companion Diagnostics for Oncology Product Market Performance
9.10.4 Abbott Business Overview
9.10.5 Abbott Recent Developments
10 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET FORECAST BY REGION
10.1 Global Companion Diagnostics for Oncology Market Size Forecast
10.2 Global Companion Diagnostics for Oncology Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Companion Diagnostics for Oncology Market Size Forecast by Country
10.2.3 Asia Pacific Companion Diagnostics for Oncology Market Size Forecast by Region
10.2.4 South America Companion Diagnostics for Oncology Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Companion Diagnostics for Oncology by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Companion Diagnostics for Oncology Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Companion Diagnostics for Oncology by Type (2025-2030)
11.1.2 Global Companion Diagnostics for Oncology Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Companion Diagnostics for Oncology by Type (2025-2030)
11.2 Global Companion Diagnostics for Oncology Market Forecast by Application (2025-2030)
11.2.1 Global Companion Diagnostics for Oncology Sales (K Units) Forecast by Application
11.2.2 Global Companion Diagnostics for Oncology Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Companion Diagnostics for Oncology
1.2 Key Market Segments
1.2.1 Companion Diagnostics for Oncology Segment by Type
1.2.2 Companion Diagnostics for Oncology Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Companion Diagnostics for Oncology Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Companion Diagnostics for Oncology Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET COMPETITIVE LANDSCAPE
3.1 Global Companion Diagnostics for Oncology Sales by Manufacturers (2019-2024)
3.2 Global Companion Diagnostics for Oncology Revenue Market Share by Manufacturers (2019-2024)
3.3 Companion Diagnostics for Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Companion Diagnostics for Oncology Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Companion Diagnostics for Oncology Sales Sites, Area Served, Product Type
3.6 Companion Diagnostics for Oncology Market Competitive Situation and Trends
3.6.1 Companion Diagnostics for Oncology Market Concentration Rate
3.6.2 Global 5 and 10 Largest Companion Diagnostics for Oncology Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 COMPANION DIAGNOSTICS FOR ONCOLOGY INDUSTRY CHAIN ANALYSIS
4.1 Companion Diagnostics for Oncology Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Companion Diagnostics for Oncology Sales Market Share by Type (2019-2024)
6.3 Global Companion Diagnostics for Oncology Market Size Market Share by Type (2019-2024)
6.4 Global Companion Diagnostics for Oncology Price by Type (2019-2024)
7 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Companion Diagnostics for Oncology Market Sales by Application (2019-2024)
7.3 Global Companion Diagnostics for Oncology Market Size (M USD) by Application (2019-2024)
7.4 Global Companion Diagnostics for Oncology Sales Growth Rate by Application (2019-2024)
8 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET SEGMENTATION BY REGION
8.1 Global Companion Diagnostics for Oncology Sales by Region
8.1.1 Global Companion Diagnostics for Oncology Sales by Region
8.1.2 Global Companion Diagnostics for Oncology Sales Market Share by Region
8.2 North America
8.2.1 North America Companion Diagnostics for Oncology Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Companion Diagnostics for Oncology Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Companion Diagnostics for Oncology Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Companion Diagnostics for Oncology Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Companion Diagnostics for Oncology Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Agilent Technologies
9.1.1 Agilent Technologies Companion Diagnostics for Oncology Basic Information
9.1.2 Agilent Technologies Companion Diagnostics for Oncology Product Overview
9.1.3 Agilent Technologies Companion Diagnostics for Oncology Product Market Performance
9.1.4 Agilent Technologies Business Overview
9.1.5 Agilent Technologies Companion Diagnostics for Oncology SWOT Analysis
9.1.6 Agilent Technologies Recent Developments
9.2 Illumina
9.2.1 Illumina Companion Diagnostics for Oncology Basic Information
9.2.2 Illumina Companion Diagnostics for Oncology Product Overview
9.2.3 Illumina Companion Diagnostics for Oncology Product Market Performance
9.2.4 Illumina Business Overview
9.2.5 Illumina Companion Diagnostics for Oncology SWOT Analysis
9.2.6 Illumina Recent Developments
9.3 Roche
9.3.1 Roche Companion Diagnostics for Oncology Basic Information
9.3.2 Roche Companion Diagnostics for Oncology Product Overview
9.3.3 Roche Companion Diagnostics for Oncology Product Market Performance
9.3.4 Roche Companion Diagnostics for Oncology SWOT Analysis
9.3.5 Roche Business Overview
9.3.6 Roche Recent Developments
9.4 BioMйrieux
9.4.1 BioMйrieux Companion Diagnostics for Oncology Basic Information
9.4.2 BioMйrieux Companion Diagnostics for Oncology Product Overview
9.4.3 BioMйrieux Companion Diagnostics for Oncology Product Market Performance
9.4.4 BioMйrieux Business Overview
9.4.5 BioMйrieux Recent Developments
9.5 Foundation Medicine
9.5.1 Foundation Medicine Companion Diagnostics for Oncology Basic Information
9.5.2 Foundation Medicine Companion Diagnostics for Oncology Product Overview
9.5.3 Foundation Medicine Companion Diagnostics for Oncology Product Market Performance
9.5.4 Foundation Medicine Business Overview
9.5.5 Foundation Medicine Recent Developments
9.6 ArcherDX
9.6.1 ArcherDX Companion Diagnostics for Oncology Basic Information
9.6.2 ArcherDX Companion Diagnostics for Oncology Product Overview
9.6.3 ArcherDX Companion Diagnostics for Oncology Product Market Performance
9.6.4 ArcherDX Business Overview
9.6.5 ArcherDX Recent Developments
9.7 Qiagen
9.7.1 Qiagen Companion Diagnostics for Oncology Basic Information
9.7.2 Qiagen Companion Diagnostics for Oncology Product Overview
9.7.3 Qiagen Companion Diagnostics for Oncology Product Market Performance
9.7.4 Qiagen Business Overview
9.7.5 Qiagen Recent Developments
9.8 Thermo Fisher Scientific
9.8.1 Thermo Fisher Scientific Companion Diagnostics for Oncology Basic Information
9.8.2 Thermo Fisher Scientific Companion Diagnostics for Oncology Product Overview
9.8.3 Thermo Fisher Scientific Companion Diagnostics for Oncology Product Market Performance
9.8.4 Thermo Fisher Scientific Business Overview
9.8.5 Thermo Fisher Scientific Recent Developments
9.9 Amoy Diagnostics
9.9.1 Amoy Diagnostics Companion Diagnostics for Oncology Basic Information
9.9.2 Amoy Diagnostics Companion Diagnostics for Oncology Product Overview
9.9.3 Amoy Diagnostics Companion Diagnostics for Oncology Product Market Performance
9.9.4 Amoy Diagnostics Business Overview
9.9.5 Amoy Diagnostics Recent Developments
9.10 Abbott
9.10.1 Abbott Companion Diagnostics for Oncology Basic Information
9.10.2 Abbott Companion Diagnostics for Oncology Product Overview
9.10.3 Abbott Companion Diagnostics for Oncology Product Market Performance
9.10.4 Abbott Business Overview
9.10.5 Abbott Recent Developments
10 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET FORECAST BY REGION
10.1 Global Companion Diagnostics for Oncology Market Size Forecast
10.2 Global Companion Diagnostics for Oncology Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Companion Diagnostics for Oncology Market Size Forecast by Country
10.2.3 Asia Pacific Companion Diagnostics for Oncology Market Size Forecast by Region
10.2.4 South America Companion Diagnostics for Oncology Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Companion Diagnostics for Oncology by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Companion Diagnostics for Oncology Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Companion Diagnostics for Oncology by Type (2025-2030)
11.1.2 Global Companion Diagnostics for Oncology Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Companion Diagnostics for Oncology by Type (2025-2030)
11.2 Global Companion Diagnostics for Oncology Market Forecast by Application (2025-2030)
11.2.1 Global Companion Diagnostics for Oncology Sales (K Units) Forecast by Application
11.2.2 Global Companion Diagnostics for Oncology Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Companion Diagnostics for Oncology Market Size Comparison by Region (M USD)
Table 5. Global Companion Diagnostics for Oncology Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Companion Diagnostics for Oncology Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Companion Diagnostics for Oncology Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Companion Diagnostics for Oncology Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics for Oncology as of 2022)
Table 10. Global Market Companion Diagnostics for Oncology Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Companion Diagnostics for Oncology Sales Sites and Area Served
Table 12. Manufacturers Companion Diagnostics for Oncology Product Type
Table 13. Global Companion Diagnostics for Oncology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Companion Diagnostics for Oncology
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Companion Diagnostics for Oncology Market Challenges
Table 22. Global Companion Diagnostics for Oncology Sales by Type (K Units)
Table 23. Global Companion Diagnostics for Oncology Market Size by Type (M USD)
Table 24. Global Companion Diagnostics for Oncology Sales (K Units) by Type (2019-2024)
Table 25. Global Companion Diagnostics for Oncology Sales Market Share by Type (2019-2024)
Table 26. Global Companion Diagnostics for Oncology Market Size (M USD) by Type (2019-2024)
Table 27. Global Companion Diagnostics for Oncology Market Size Share by Type (2019-2024)
Table 28. Global Companion Diagnostics for Oncology Price (USD/Unit) by Type (2019-2024)
Table 29. Global Companion Diagnostics for Oncology Sales (K Units) by Application
Table 30. Global Companion Diagnostics for Oncology Market Size by Application
Table 31. Global Companion Diagnostics for Oncology Sales by Application (2019-2024) & (K Units)
Table 32. Global Companion Diagnostics for Oncology Sales Market Share by Application (2019-2024)
Table 33. Global Companion Diagnostics for Oncology Sales by Application (2019-2024) & (M USD)
Table 34. Global Companion Diagnostics for Oncology Market Share by Application (2019-2024)
Table 35. Global Companion Diagnostics for Oncology Sales Growth Rate by Application (2019-2024)
Table 36. Global Companion Diagnostics for Oncology Sales by Region (2019-2024) & (K Units)
Table 37. Global Companion Diagnostics for Oncology Sales Market Share by Region (2019-2024)
Table 38. North America Companion Diagnostics for Oncology Sales by Country (2019-2024) & (K Units)
Table 39. Europe Companion Diagnostics for Oncology Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Companion Diagnostics for Oncology Sales by Region (2019-2024) & (K Units)
Table 41. South America Companion Diagnostics for Oncology Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Companion Diagnostics for Oncology Sales by Region (2019-2024) & (K Units)
Table 43. Agilent Technologies Companion Diagnostics for Oncology Basic Information
Table 44. Agilent Technologies Companion Diagnostics for Oncology Product Overview
Table 45. Agilent Technologies Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Agilent Technologies Business Overview
Table 47. Agilent Technologies Companion Diagnostics for Oncology SWOT Analysis
Table 48. Agilent Technologies Recent Developments
Table 49. Illumina Companion Diagnostics for Oncology Basic Information
Table 50. Illumina Companion Diagnostics for Oncology Product Overview
Table 51. Illumina Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Illumina Business Overview
Table 53. Illumina Companion Diagnostics for Oncology SWOT Analysis
Table 54. Illumina Recent Developments
Table 55. Roche Companion Diagnostics for Oncology Basic Information
Table 56. Roche Companion Diagnostics for Oncology Product Overview
Table 57. Roche Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Roche Companion Diagnostics for Oncology SWOT Analysis
Table 59. Roche Business Overview
Table 60. Roche Recent Developments
Table 61. BioMйrieux Companion Diagnostics for Oncology Basic Information
Table 62. BioMйrieux Companion Diagnostics for Oncology Product Overview
Table 63. BioMйrieux Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. BioMйrieux Business Overview
Table 65. BioMйrieux Recent Developments
Table 66. Foundation Medicine Companion Diagnostics for Oncology Basic Information
Table 67. Foundation Medicine Companion Diagnostics for Oncology Product Overview
Table 68. Foundation Medicine Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Foundation Medicine Business Overview
Table 70. Foundation Medicine Recent Developments
Table 71. ArcherDX Companion Diagnostics for Oncology Basic Information
Table 72. ArcherDX Companion Diagnostics for Oncology Product Overview
Table 73. ArcherDX Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. ArcherDX Business Overview
Table 75. ArcherDX Recent Developments
Table 76. Qiagen Companion Diagnostics for Oncology Basic Information
Table 77. Qiagen Companion Diagnostics for Oncology Product Overview
Table 78. Qiagen Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Qiagen Business Overview
Table 80. Qiagen Recent Developments
Table 81. Thermo Fisher Scientific Companion Diagnostics for Oncology Basic Information
Table 82. Thermo Fisher Scientific Companion Diagnostics for Oncology Product Overview
Table 83. Thermo Fisher Scientific Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Thermo Fisher Scientific Business Overview
Table 85. Thermo Fisher Scientific Recent Developments
Table 86. Amoy Diagnostics Companion Diagnostics for Oncology Basic Information
Table 87. Amoy Diagnostics Companion Diagnostics for Oncology Product Overview
Table 88. Amoy Diagnostics Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Amoy Diagnostics Business Overview
Table 90. Amoy Diagnostics Recent Developments
Table 91. Abbott Companion Diagnostics for Oncology Basic Information
Table 92. Abbott Companion Diagnostics for Oncology Product Overview
Table 93. Abbott Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Abbott Business Overview
Table 95. Abbott Recent Developments
Table 96. Global Companion Diagnostics for Oncology Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Companion Diagnostics for Oncology Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Companion Diagnostics for Oncology Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Companion Diagnostics for Oncology Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Companion Diagnostics for Oncology Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Companion Diagnostics for Oncology Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Companion Diagnostics for Oncology Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Companion Diagnostics for Oncology Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Companion Diagnostics for Oncology Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Companion Diagnostics for Oncology Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Companion Diagnostics for Oncology Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Companion Diagnostics for Oncology Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Companion Diagnostics for Oncology Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Companion Diagnostics for Oncology Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Companion Diagnostics for Oncology Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Companion Diagnostics for Oncology Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Companion Diagnostics for Oncology Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Companion Diagnostics for Oncology Market Size Comparison by Region (M USD)
Table 5. Global Companion Diagnostics for Oncology Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Companion Diagnostics for Oncology Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Companion Diagnostics for Oncology Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Companion Diagnostics for Oncology Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics for Oncology as of 2022)
Table 10. Global Market Companion Diagnostics for Oncology Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Companion Diagnostics for Oncology Sales Sites and Area Served
Table 12. Manufacturers Companion Diagnostics for Oncology Product Type
Table 13. Global Companion Diagnostics for Oncology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Companion Diagnostics for Oncology
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Companion Diagnostics for Oncology Market Challenges
Table 22. Global Companion Diagnostics for Oncology Sales by Type (K Units)
Table 23. Global Companion Diagnostics for Oncology Market Size by Type (M USD)
Table 24. Global Companion Diagnostics for Oncology Sales (K Units) by Type (2019-2024)
Table 25. Global Companion Diagnostics for Oncology Sales Market Share by Type (2019-2024)
Table 26. Global Companion Diagnostics for Oncology Market Size (M USD) by Type (2019-2024)
Table 27. Global Companion Diagnostics for Oncology Market Size Share by Type (2019-2024)
Table 28. Global Companion Diagnostics for Oncology Price (USD/Unit) by Type (2019-2024)
Table 29. Global Companion Diagnostics for Oncology Sales (K Units) by Application
Table 30. Global Companion Diagnostics for Oncology Market Size by Application
Table 31. Global Companion Diagnostics for Oncology Sales by Application (2019-2024) & (K Units)
Table 32. Global Companion Diagnostics for Oncology Sales Market Share by Application (2019-2024)
Table 33. Global Companion Diagnostics for Oncology Sales by Application (2019-2024) & (M USD)
Table 34. Global Companion Diagnostics for Oncology Market Share by Application (2019-2024)
Table 35. Global Companion Diagnostics for Oncology Sales Growth Rate by Application (2019-2024)
Table 36. Global Companion Diagnostics for Oncology Sales by Region (2019-2024) & (K Units)
Table 37. Global Companion Diagnostics for Oncology Sales Market Share by Region (2019-2024)
Table 38. North America Companion Diagnostics for Oncology Sales by Country (2019-2024) & (K Units)
Table 39. Europe Companion Diagnostics for Oncology Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Companion Diagnostics for Oncology Sales by Region (2019-2024) & (K Units)
Table 41. South America Companion Diagnostics for Oncology Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Companion Diagnostics for Oncology Sales by Region (2019-2024) & (K Units)
Table 43. Agilent Technologies Companion Diagnostics for Oncology Basic Information
Table 44. Agilent Technologies Companion Diagnostics for Oncology Product Overview
Table 45. Agilent Technologies Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Agilent Technologies Business Overview
Table 47. Agilent Technologies Companion Diagnostics for Oncology SWOT Analysis
Table 48. Agilent Technologies Recent Developments
Table 49. Illumina Companion Diagnostics for Oncology Basic Information
Table 50. Illumina Companion Diagnostics for Oncology Product Overview
Table 51. Illumina Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Illumina Business Overview
Table 53. Illumina Companion Diagnostics for Oncology SWOT Analysis
Table 54. Illumina Recent Developments
Table 55. Roche Companion Diagnostics for Oncology Basic Information
Table 56. Roche Companion Diagnostics for Oncology Product Overview
Table 57. Roche Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Roche Companion Diagnostics for Oncology SWOT Analysis
Table 59. Roche Business Overview
Table 60. Roche Recent Developments
Table 61. BioMйrieux Companion Diagnostics for Oncology Basic Information
Table 62. BioMйrieux Companion Diagnostics for Oncology Product Overview
Table 63. BioMйrieux Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. BioMйrieux Business Overview
Table 65. BioMйrieux Recent Developments
Table 66. Foundation Medicine Companion Diagnostics for Oncology Basic Information
Table 67. Foundation Medicine Companion Diagnostics for Oncology Product Overview
Table 68. Foundation Medicine Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Foundation Medicine Business Overview
Table 70. Foundation Medicine Recent Developments
Table 71. ArcherDX Companion Diagnostics for Oncology Basic Information
Table 72. ArcherDX Companion Diagnostics for Oncology Product Overview
Table 73. ArcherDX Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. ArcherDX Business Overview
Table 75. ArcherDX Recent Developments
Table 76. Qiagen Companion Diagnostics for Oncology Basic Information
Table 77. Qiagen Companion Diagnostics for Oncology Product Overview
Table 78. Qiagen Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Qiagen Business Overview
Table 80. Qiagen Recent Developments
Table 81. Thermo Fisher Scientific Companion Diagnostics for Oncology Basic Information
Table 82. Thermo Fisher Scientific Companion Diagnostics for Oncology Product Overview
Table 83. Thermo Fisher Scientific Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Thermo Fisher Scientific Business Overview
Table 85. Thermo Fisher Scientific Recent Developments
Table 86. Amoy Diagnostics Companion Diagnostics for Oncology Basic Information
Table 87. Amoy Diagnostics Companion Diagnostics for Oncology Product Overview
Table 88. Amoy Diagnostics Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Amoy Diagnostics Business Overview
Table 90. Amoy Diagnostics Recent Developments
Table 91. Abbott Companion Diagnostics for Oncology Basic Information
Table 92. Abbott Companion Diagnostics for Oncology Product Overview
Table 93. Abbott Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Abbott Business Overview
Table 95. Abbott Recent Developments
Table 96. Global Companion Diagnostics for Oncology Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Companion Diagnostics for Oncology Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Companion Diagnostics for Oncology Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Companion Diagnostics for Oncology Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Companion Diagnostics for Oncology Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Companion Diagnostics for Oncology Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Companion Diagnostics for Oncology Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Companion Diagnostics for Oncology Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Companion Diagnostics for Oncology Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Companion Diagnostics for Oncology Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Companion Diagnostics for Oncology Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Companion Diagnostics for Oncology Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Companion Diagnostics for Oncology Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Companion Diagnostics for Oncology Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Companion Diagnostics for Oncology Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Companion Diagnostics for Oncology Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Companion Diagnostics for Oncology Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Companion Diagnostics for Oncology
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Companion Diagnostics for Oncology Market Size (M USD), 2019-2030
Figure 5. Global Companion Diagnostics for Oncology Market Size (M USD) (2019-2030)
Figure 6. Global Companion Diagnostics for Oncology Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Companion Diagnostics for Oncology Market Size by Country (M USD)
Figure 11. Companion Diagnostics for Oncology Sales Share by Manufacturers in 2023
Figure 12. Global Companion Diagnostics for Oncology Revenue Share by Manufacturers in 2023
Figure 13. Companion Diagnostics for Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Companion Diagnostics for Oncology Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Companion Diagnostics for Oncology Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Companion Diagnostics for Oncology Market Share by Type
Figure 18. Sales Market Share of Companion Diagnostics for Oncology by Type (2019-2024)
Figure 19. Sales Market Share of Companion Diagnostics for Oncology by Type in 2023
Figure 20. Market Size Share of Companion Diagnostics for Oncology by Type (2019-2024)
Figure 21. Market Size Market Share of Companion Diagnostics for Oncology by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Companion Diagnostics for Oncology Market Share by Application
Figure 24. Global Companion Diagnostics for Oncology Sales Market Share by Application (2019-2024)
Figure 25. Global Companion Diagnostics for Oncology Sales Market Share by Application in 2023
Figure 26. Global Companion Diagnostics for Oncology Market Share by Application (2019-2024)
Figure 27. Global Companion Diagnostics for Oncology Market Share by Application in 2023
Figure 28. Global Companion Diagnostics for Oncology Sales Growth Rate by Application (2019-2024)
Figure 29. Global Companion Diagnostics for Oncology Sales Market Share by Region (2019-2024)
Figure 30. North America Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Companion Diagnostics for Oncology Sales Market Share by Country in 2023
Figure 32. U.S. Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Companion Diagnostics for Oncology Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Companion Diagnostics for Oncology Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Companion Diagnostics for Oncology Sales Market Share by Country in 2023
Figure 37. Germany Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Companion Diagnostics for Oncology Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Companion Diagnostics for Oncology Sales Market Share by Region in 2023
Figure 44. China Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Companion Diagnostics for Oncology Sales and Growth Rate (K Units)
Figure 50. South America Companion Diagnostics for Oncology Sales Market Share by Country in 2023
Figure 51. Brazil Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Companion Diagnostics for Oncology Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Companion Diagnostics for Oncology Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Companion Diagnostics for Oncology Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Companion Diagnostics for Oncology Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Companion Diagnostics for Oncology Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Companion Diagnostics for Oncology Market Share Forecast by Type (2025-2030)
Figure 65. Global Companion Diagnostics for Oncology Sales Forecast by Application (2025-2030)
Figure 66. Global Companion Diagnostics for Oncology Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Companion Diagnostics for Oncology
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Companion Diagnostics for Oncology Market Size (M USD), 2019-2030
Figure 5. Global Companion Diagnostics for Oncology Market Size (M USD) (2019-2030)
Figure 6. Global Companion Diagnostics for Oncology Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Companion Diagnostics for Oncology Market Size by Country (M USD)
Figure 11. Companion Diagnostics for Oncology Sales Share by Manufacturers in 2023
Figure 12. Global Companion Diagnostics for Oncology Revenue Share by Manufacturers in 2023
Figure 13. Companion Diagnostics for Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Companion Diagnostics for Oncology Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Companion Diagnostics for Oncology Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Companion Diagnostics for Oncology Market Share by Type
Figure 18. Sales Market Share of Companion Diagnostics for Oncology by Type (2019-2024)
Figure 19. Sales Market Share of Companion Diagnostics for Oncology by Type in 2023
Figure 20. Market Size Share of Companion Diagnostics for Oncology by Type (2019-2024)
Figure 21. Market Size Market Share of Companion Diagnostics for Oncology by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Companion Diagnostics for Oncology Market Share by Application
Figure 24. Global Companion Diagnostics for Oncology Sales Market Share by Application (2019-2024)
Figure 25. Global Companion Diagnostics for Oncology Sales Market Share by Application in 2023
Figure 26. Global Companion Diagnostics for Oncology Market Share by Application (2019-2024)
Figure 27. Global Companion Diagnostics for Oncology Market Share by Application in 2023
Figure 28. Global Companion Diagnostics for Oncology Sales Growth Rate by Application (2019-2024)
Figure 29. Global Companion Diagnostics for Oncology Sales Market Share by Region (2019-2024)
Figure 30. North America Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Companion Diagnostics for Oncology Sales Market Share by Country in 2023
Figure 32. U.S. Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Companion Diagnostics for Oncology Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Companion Diagnostics for Oncology Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Companion Diagnostics for Oncology Sales Market Share by Country in 2023
Figure 37. Germany Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Companion Diagnostics for Oncology Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Companion Diagnostics for Oncology Sales Market Share by Region in 2023
Figure 44. China Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Companion Diagnostics for Oncology Sales and Growth Rate (K Units)
Figure 50. South America Companion Diagnostics for Oncology Sales Market Share by Country in 2023
Figure 51. Brazil Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Companion Diagnostics for Oncology Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Companion Diagnostics for Oncology Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Companion Diagnostics for Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Companion Diagnostics for Oncology Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Companion Diagnostics for Oncology Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Companion Diagnostics for Oncology Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Companion Diagnostics for Oncology Market Share Forecast by Type (2025-2030)
Figure 65. Global Companion Diagnostics for Oncology Sales Forecast by Application (2025-2030)
Figure 66. Global Companion Diagnostics for Oncology Market Share Forecast by Application (2025-2030)
